4,030 Shares in Cigna Group $CI Purchased by Cambient Family Office LLC

Cambient Family Office LLC acquired a new stake in shares of Cigna Group (NYSE:CI) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 4,030 shares of the health services provider’s stock, valued at approximately $1,109,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Wilkerson Advisory Group LLC bought a new position in shares of Cigna Group in the fourth quarter worth approximately $25,000. Beacon Financial Strategies CORP bought a new stake in shares of Cigna Group during the fourth quarter valued at approximately $28,000. Kemnay Advisory Services Inc. bought a new stake in shares of Cigna Group during the fourth quarter valued at approximately $29,000. Prosperity Bancshares Inc purchased a new position in Cigna Group in the 4th quarter worth approximately $29,000. Finally, Lodestone Wealth Management LLC purchased a new position in Cigna Group in the 4th quarter worth approximately $32,000. 86.99% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.60% of the company’s stock.

Cigna Group Stock Down 1.9%

Shares of Cigna Group stock opened at $279.63 on Friday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company’s 50 day moving average is $283.75 and its 200 day moving average is $278.32. The company has a market cap of $73.97 billion, a price-to-earnings ratio of 11.85, a price-to-earnings-growth ratio of 1.10 and a beta of 0.28.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts anticipate that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were issued a $1.56 dividend. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 26.45%.

Wall Street Analyst Weigh In

CI has been the topic of several recent analyst reports. Wells Fargo & Company increased their target price on Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. Wolfe Research restated an “outperform” rating and issued a $315.00 price target on shares of Cigna Group in a research note on Tuesday. Morgan Stanley upped their price target on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Guggenheim increased their price objective on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Finally, Mizuho lifted their price objective on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and an average target price of $338.30.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.